Showing results (311-320 of 684) with videos related to
Sort By:
Pageof 69
ACS Omega|February 19, 2019
Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal StructureWolfgang Dohle, Andrea E Prota, Grégory Menchon, et al.The Journal of Urology|March 1, 1985
Renal and perirenal infection: the role of computerized tomographyJ G Bova, J L Potter, E Arevalos, et al.Journal of Medicinal Chemistry|October 31, 2003
Synthesis and Ca2+-mobilizing activity of purine-modified mimics of adenophostin A: a model for the adenophostin-Ins(1,4,5)P3 receptor interactionHeidi J Rosenberg, Andrew M Riley, Alex J Laude, et al.Journal of Thoracic Disease|October 24, 2024
Primary lung signet-ring cell carcinoma: a national analysisArian Mansur, Zain Saleem, Alexandra L Potter, et al.Quality Management in Health Care|March 3, 1998
Competency in health care management: a training model in epidemiologic methods for assessing and improving the quality of clinical practice through evidence-based decision makingR P Hudak, I Jacoby, G S Meyer, et al.Medchemcomm|August 7, 2018
A synthetic diphosphoinositol phosphate analogue of inositol trisphosphateAndrew M Riley, Judith Unterlass, Vera Konieczny, et al.Biochemical and Biophysical Research Communications|July 14, 2004
D-6-Deoxy-myo-inositol 1,3,4,5-tetrakisphosphate, a mimic of d-myo-inositol 1,3,4,5-tetrakisphosphate: biological activity and pH-dependent conformational propertiesGraeme Horne, Clarisse Maechling, Andrea Fleig, et al.Journal of Inherited Metabolic Disease|July 24, 2008
Correlates of language impairment in children with galactosaemiaN L Potter, J-A C Lazarus, J M Johnson, et al.The Biochemical Journal|January 4, 2013
Subtype-selective regulation of IP(3) receptors by thimerosal via cysteine residues within the IP(3)-binding core and suppressor domainSamir A Khan, Ana M Rossi, Andrew M Riley, et al.Endocrinology|May 3, 2008
The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancerPaul A Foster, L W Lawrence Woo, Barry V L Potter, et al.Pageof 69